tiprankstipranks
Trending News
More News >
Oruka Therapeutics (ORKA)
NASDAQ:ORKA

Compare Oruka Therapeutics (ORKA) vs. Competitors

Compare
743 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Oruka Therapeutics
$34.23
$1.66B
-14.16
170.17%
11 Buy
0 Hold
0 Sell
Strong Buy
Verastem
$6.10
$459.45M
-1.93%
5 Buy
0 Hold
0 Sell
Strong Buy
AnaptysBio
$47.41
$1.31B
-16.82
172.16%
9 Buy
1 Hold
0 Sell
Strong Buy
Compass Therapeutics
$6.40
$1.14B
-13.99
111.92%
8 Buy
0 Hold
0 Sell
Strong Buy
Olema Pharmaceuticals
$25.72
$2.02B
-14.19
306.32%
11 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$16.80
$920.34M
-7.53
30.13%
9 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ORKA
Oruka Therapeutics
34.23
20.53
149.85%
VSTM
Verastem
6.10
0.39
6.83%
ANAB
AnaptysBio
47.41
30.75
184.57%
CMPX
Compass Therapeutics
6.40
3.32
107.79%
OLMA
Olema Pharmaceuticals
25.72
19.76
331.54%
BCAX
Bicara Therapeutics Inc.
16.80
4.50
36.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts